Patent 11071751 was granted and assigned to Decibel Therapeutics on July, 2021 by the United States Patent and Trademark Office.
Hypertonic pharmaceutical compositions are disclosed. The hypertonic pharmaceutical compositions contain an anti-platinum chemoprotectant agent and a gelling agent. Also disclosed are methods of medical use of the hypertonic pharmaceutical compositions.